IBBQ logoIBBQ
Invesco Nasdaq Biotechnology ETF

45
Loading...
Loading...
News
all
press releases
News Placeholder
Mesoblast Gives Positive Update About Potential FDA Application For Heart Failure Therapy: Retail Sees ‘Inflection Point’
The company is also looking forward to a meeting with the FDA in early July to discuss a trial of Ryoncil in adults with steroid-refractory acute graft-versus-host disease.
Stocktwits·3mo ago
News Placeholder
How Is Viatris’ Stock Performance Compared to Other Biotech Stocks?
Over the past six months, Viatris has lagged behind its biotech peers, and Wall Street analysts continue to exercise caution regarding the stock's future outlook.
barchart.com·5mo ago
News Placeholder
Tempus AI Stock Eyes Best Rally In 5 Months Amid Pelosi-Linked Hype, But Retail’s Turning Doubtful Now
A regulatory filing from Wednesday night disclosed that Tempus AI founder and CEO Eric Lefkofsky sold 946,084 shares of Tempus between Jan. 15-17.
Stocktwits·8mo ago

Latest IBBQ News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.